What's breaking now, across thousands of outlets.
What does this mean? Don't miss a story, subscribe here.
We haven't written up this one. ScienceAlert has the full story — the link below goes straight to it.
(MedPage Today) -- The anti-CD20 agent rituximab was associated with a higher risk of inflammatory bowel disease (IBD) in people with relapsing-remitting multiple sclerosis (MS) compared with other…
To invade red blood cells, the deadly protist creates a temporary molecular portal that disappears behind it — a door we can now see in fine detail.
As a Boston judge heard a challenge to Medicaid work requirements, state Medicaid directors gathered in Maryland to figure out how to implement those sweeping changes.
Quest is the latest in a series of healthcare technology companies that have been hacked in recent months.
Another day, another Roche deal. The Swiss pharma is teaming up with Zymeworks, paying $55 million upfront for worldwide rights to a trispecific T cell engager (TCE) that could go head-to-head with…
